Answers are grounded in this paper and cite their sources.
With bystander effect and tumor specificity, the Herpes Simplex Virus-Thymidine kinase (HSV-TK)/Ganciclovir (GCV) system is a powerful suicide gene therapy against cancers, including melanoma. Both viral and non-viral vectors have been used to deliver HSV-TK DNA. Previous studies revealed that tissue-specific delivery of mRNAs by non-viral vectors is a highly effective and safer approach for the expression of therapeutic proteins. Herein, we report targeted delivery of mRNA encoding HSV-TK to melanoma with metastasis by a ligand-functionalized lipid nanoparticle (LNP) containing an ionizable and charge-reversal lipid. Screening of a library of newly synthesized lipids containing an ester group at the terminus of the lipid chain identified Glu4 as the most effective RNA-binding lipid with the prompt charge reversal via hydrolysis of the end-group ester bond. Incorporation of adenosine-conjugated lipid (Ad4-DoGo4) into Glu4 resulted in a tumor-enriched LNP (denoted by GA3 LNP) with highly effective mRNA delivery in B16-F10 tumor and its metastasis. The delivery of HSV-TK mRNA by GA3 LNP, combined with co-administration of GCV, significantly inhibited both tumor growth and pulmonary metastasis. Collectively, our findings demonstrate that GA3 LNP represents a promising carrier for the tumor-targeted delivery of therapeutic mRNA.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: